{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-30470553-linaclotide:v1","objectPathId":"pubmed-pmid-30470553-linaclotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-30470553-linaclotide/","json":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-30470553-linaclotide-v1.json","markdown":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-30470553-linaclotide-v1.md"},"story":{"slug":"pubmed-pmid-30470553-linaclotide","version":1,"domain":"Literature metadata","dateInSource":"2019-06-13","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-13","peptideSlugs":["linaclotide"],"peptides":[{"slug":"linaclotide","url":"https://peptidescanner.com/peptides/linaclotide/"}]},"claims":[{"id":"headline","text":"Long-term treatment with linaclotide of intestinal pseudo-obstruction secondary to Ehlers-Danlos syndrome.","sourceIds":["pubmed-observation-pmid-30470553-2019-06-13-14e2cd939160"]},{"id":"summary","text":"PubMed lists PMID 30470553 in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver as Letter, with publication-date metadata of 2018-10-28 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-30470553-2019-06-13-14e2cd939160"]},{"id":"paragraph-1","text":"PubMed lists PMID 30470553 in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver as Letter, with publication-date metadata of 2018-10-28 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-30470553-2019-06-13-14e2cd939160"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-30470553-2019-06-13-14e2cd939160"]}],"sources":[{"id":"pubmed-observation-pmid-30470553-2019-06-13-14e2cd939160","name":"PubMed","sourceClass":"A","title":"Long-term treatment with linaclotide of intestinal pseudo-obstruction secondary to Ehlers-Danlos syndrome. · retained source version 1:2019-06-13:current:14e2cd939160719beb7a660d9f0c77e181cca2acc1b15db047be2e1ffef96943","url":"https://pubmed.ncbi.nlm.nih.gov/30470553/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"17ba1ba7fa411518c62f5f130db72da73c37e27eded8081e8f0b7f7f8f7e5115","tierARecordSha256":"805276cd31c685e6b38c1c201ae5d87b9cd3d5147454f7db780b4aaf8f97de92"},"integrity":{"algorithm":"sha256","contentSha256":"217aeac8647a98ec7727ccfa8aafbf488e85bf8d74b37a3aa9701af9bdb285b0"}}